Analysts forecast the Global Ankylosing Spondylitis market to grow at a CAGR of 5.05 percent over the period 2014-2019.
This report covers the present scenario and the growth prospects of the Global Ankylosing Spondylitis market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of ankylosing spondylitis. The market is segmented based on the mechanism of action of the drugs used to treat ankylosing spondylitis as illustrated below:
- TNF Inhibitors
- COX Inhibitors
On the type of molecule used for the treatment of ankylosing spondylitis, as illustrated below:
- Small Molecules
On the basis of route of administration adopted for the treatment of ankylosing spondylitis, the Global Ankylosing Spondylitis market is segmented as follows:
In addition, the market is also bifurcated on the basis of dosage forms of the drugs used in the treatment of the disease:
Order a copy of this report at (Prices start at US $3000 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=29501 .
The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Also, the late-stage pipeline molecules developed for the treatment of Ankylosing Spondylitis have been discussed.
Global Ankylosing Spondylitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region and the EMEA; it also covers the Global Ankylosing Spondylitis market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.
- Janssen Pharmaceuticals
- Merck & Co.
Other Prominent Vendors
- Boehringer Ingelheim
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Merck Sharp & Dohme
- Otsuka Pharmaceutical
- Regeneron Pharmaceuticals
- Shanghai Pharmaceuticals
- Presence of Unmet Need
- Threat from Patent Expiry
- Market Dominance by Biologics
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=29501 .
End of Year Discounts: A discount of 20% on all reports by Infiniti Research Limited, published until the 24th of September 2014. Discount available till 15th January 2015.
Sandlerresearch.org (http://www.sandlerresearch.org) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.